Santen Pharmaceutical Co (JP:4536) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Santen Pharmaceutical Co., Ltd. has resolved to dispose of 30,715 treasury shares on September 30, 2024, to fulfill obligations under its Performance Share Unit (PSU) plan for directors and corporate officers. The disposal at 1,816.0 yen per share will total 55,778,440 yen, rewarding participants based on the company’s performance from FY2021 to FY2023. This move is aimed at aligning the interests of executives with those of shareholders by providing medium- to long-term incentives.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue